Daniel Von Hoff

19PUBLICATIONS
161CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseasesMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

|Sep 02, 2025
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma.

Kuntal Halder, Erkut H Borazanci, Gayle S Jameson

|Jul 29, 2025
Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease.

R M Imtiaz Karim Rony, Alireza Shokrani, Naseeb Kaur Malhi

|Jun 25, 2025
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors.

Philippe A Cassier, Mitesh J Borad, Sunil Sharma

|Oct 04, 2024
Vitamin A Metabolism and Resistance of Hepatic Metastases to Immunotherapy.

Peter C Jones, Daniel D Von Hoff

|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan

Pageof 4

Frequent Collaborators

9 joint publications

Haiyong Han

4 joint publications

Ronald M Evans

3 joint publications

Corina E Antal

3 joint publications

Ruth T Yu